Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa C Rohan

Showing results (51-60 of 84) with videos related to

Pageof 9
Sort By:
Biomaterials|August 31, 2011
Inhibition of the transport of HIV in vitro using a pH-responsive synthetic mucin-like polymer systemAlamelu Mahalingam, Julie I Jay, Kristofer Langheinrich, et al.
Plos One|February 9, 2013
A compensatory mutation provides resistance to disparate HIV fusion inhibitor peptides and enhances membrane fusionMatthew P Wood, Amy L Cole, Piotr Ruchala, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 15, 2017
Comparison of the Pharmacokinetics and Pharmacodynamics of Single-Dose Tenofovir Vaginal Film and Gel Formulation (FAME 05)Jennifer A Robinson, Mark A Marzinke, Edward J Fuchs, et al.
Frontiers in Veterinary Science|March 9, 2026
Pharmacokinetics and preliminary data on safety of meloxicam subcutaneous extended-release formulation in Sprague-Dawley ratsAvantika Gupta, Harshita Akkaraju, Vignesh Vasudevan, et al.
Journal of Clinical Pharmacology|February 17, 2026
Mechanism-Based Predictions of Local Tissue and Systemic Exposure for Drug Products Delivered Through the Female Reproductive TractXinnong Li, Thomas Straubinger, Lisa C Rohan, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 18, 2012
Retrocyclin RC-101 blocks HIV-1 transmission across cervical mucosa in an organ culturePhalguni Gupta, Deena Ratner, Ming Ding, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 5, 2016
Structural basis of HIV inhibition by translocation-defective RT inhibitor 4'-ethynyl-2-fluoro-2'-deoxyadenosine (EFdA)Zhe Li Salie, Karen A Kirby, Eleftherios Michailidis, et al.
Polymers|March 26, 2022
Development and Evaluation of Nanoparticles-in-Film Technology to Achieve Extended In Vivo Exposure of MK-2048 for HIV PreventionXin Tong, Sravan Kumar Patel, Jing Li, et al.
Pharmaceutics|August 28, 2021
Development, Characterization and In Vivo Pharmacokinetic Assessment of Rectal Suppositories Containing Combination Antiretroviral Drugs for HIV PreventionKunal Jhunjhunwala, Charles W Dobard, Sunita Sharma, et al.
Medicine|July 19, 2016
Pharmacodynamic correlations using fresh and cryopreserved tissue following use of vaginal rings containing dapivirine and/or maraviroc in a randomized, placebo controlled trialCharlene S Dezzutti, Nicola Richardson-Harman, Lisa C Rohan, et al.
Pageof 9

Showing results (51-60 of 84) with videos related to

Sort By:
Pageof 9
Biomaterials|August 31, 2011
Inhibition of the transport of HIV in vitro using a pH-responsive synthetic mucin-like polymer systemAlamelu Mahalingam, Julie I Jay, Kristofer Langheinrich, et al.
Plos One|February 9, 2013
A compensatory mutation provides resistance to disparate HIV fusion inhibitor peptides and enhances membrane fusionMatthew P Wood, Amy L Cole, Piotr Ruchala, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 15, 2017
Comparison of the Pharmacokinetics and Pharmacodynamics of Single-Dose Tenofovir Vaginal Film and Gel Formulation (FAME 05)Jennifer A Robinson, Mark A Marzinke, Edward J Fuchs, et al.
Frontiers in Veterinary Science|March 9, 2026
Pharmacokinetics and preliminary data on safety of meloxicam subcutaneous extended-release formulation in Sprague-Dawley ratsAvantika Gupta, Harshita Akkaraju, Vignesh Vasudevan, et al.
Journal of Clinical Pharmacology|February 17, 2026
Mechanism-Based Predictions of Local Tissue and Systemic Exposure for Drug Products Delivered Through the Female Reproductive TractXinnong Li, Thomas Straubinger, Lisa C Rohan, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 18, 2012
Retrocyclin RC-101 blocks HIV-1 transmission across cervical mucosa in an organ culturePhalguni Gupta, Deena Ratner, Ming Ding, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 5, 2016
Structural basis of HIV inhibition by translocation-defective RT inhibitor 4'-ethynyl-2-fluoro-2'-deoxyadenosine (EFdA)Zhe Li Salie, Karen A Kirby, Eleftherios Michailidis, et al.
Polymers|March 26, 2022
Development and Evaluation of Nanoparticles-in-Film Technology to Achieve Extended In Vivo Exposure of MK-2048 for HIV PreventionXin Tong, Sravan Kumar Patel, Jing Li, et al.
Pharmaceutics|August 28, 2021
Development, Characterization and In Vivo Pharmacokinetic Assessment of Rectal Suppositories Containing Combination Antiretroviral Drugs for HIV PreventionKunal Jhunjhunwala, Charles W Dobard, Sunita Sharma, et al.
Medicine|July 19, 2016
Pharmacodynamic correlations using fresh and cryopreserved tissue following use of vaginal rings containing dapivirine and/or maraviroc in a randomized, placebo controlled trialCharlene S Dezzutti, Nicola Richardson-Harman, Lisa C Rohan, et al.
Pageof 9